imutex.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: /wp-admin/ Allow:
Meta Tags
Title Vaccine Programmes | Vaccine Development |
Description About Vaccine programmes. A joint venture between PepTcell and hVIVO, Imutex is developing vaccines against influenza and mosquito borne diseases. Find out
Keywords N/A
Server Information
WebSite imutex faviconimutex.com
Host IP 35.197.237.253
Location United States
Related Websites
Site Rank
More to Explore
imutex.com Valuation
US$283,550
Last updated: 2023-05-18 20:54:01

imutex.com has Semrush global rank of 37,327,849. imutex.com has an estimated worth of US$ 283,550, based on its estimated Ads revenue. imutex.com receives approximately 32,718 unique visitors each day. Its web server is located in United States, with IP address 35.197.237.253. According to SiteAdvisor, imutex.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$283,550
Daily Ads Revenue US$262
Monthly Ads Revenue US$7,853
Yearly Ads Revenue US$94,226
Daily Unique Visitors 2,182
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
imutex.com. A 3600 IP: 35.197.237.253
imutex.com. NS 3600 NS Record: pdns05.domaincontrol.com.
imutex.com. NS 3600 NS Record: pdns06.domaincontrol.com.
HtmlToTextCheckTime:2023-05-18 20:54:01
Toggle navigation ABOUT FLU VACCINE PROGRAMME MOSQUITO-BORNE DISEASES LEADERSHIP NEWS CONTACT FLU VACCINE PROGRAMME Imutex is leveraging technology licensed from PepTcell to develop a Broad-Spectrum ‘Universal’ Influenza Vaccine (BIV), called FLU-v, against multiple flu strains. Read More MOSQUITO-BORNE DISEASES AGS-v is a mosquito-borne disease vaccine with a novel proposed dual action mechanism of preventing infection in humans whilst controlling the mosquito population. Read More LEADERSHIP Led by an experienced Board of Directors and experts from both hVIVO plc and PepTcell Read More CONTACT US Contact us today to find out more information regarding our products! Get in Touch Previous Next About Imutex Imutex Limited is a joint venture between PepTcell (51%) and hVIVO plc (49%). The Imutex vaccines have been designed to provide a broadly protective immune response against disease through viral clearance by cytotoxic T cells secreting pro-inflammatory cytokines and cytotoxic
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sat, 23 Jul 2022 08:50:29 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: https://imutex.com/

HTTP/2 200 
server: nginx
date: Sat, 23 Jul 2022 08:50:29 GMT
content-type: text/html; charset=UTF-8
content-length: 67217
vary: Accept-Encoding
vary: Accept-Encoding
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-cache-group: normal
accept-ranges: bytes
imutex.com Whois Information
Domain Name: IMUTEX.COM
Registry Domain ID: 2022440590_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-10-26T09:05:53Z
Creation Date: 2016-04-18T15:14:40Z
Registry Expiry Date: 2026-04-18T15:14:40Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: PDNS05.DOMAINCONTROL.COM
Name Server: PDNS06.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-07-23T08:54:12Z <<<

Copyright © 2022 WebZZ.US 0.0318